ERBB2 and breast carcinoma: One example of prior work is translational research from PALOMA-3, a phase III multicenter, double-blind randomized control trial of Palbociclib plus Fulvestrant vs placebo plus Fulvestrant in women with HR+/HER2− advanced breast cancer.